Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 173

1.

[Safety evaluation and risk control measures for Aconiti Kusnezoffii Radix].

Wang D, Jia DX, Li ZZ, Yao JK, Zhang L, Sun XB, Gao XM, Wang JX.

Zhongguo Zhong Yao Za Zhi. 2018 Aug;43(15):3093-3100. doi: 10.19540/j.cnki.cjcmm.20180516.006. Review. Chinese.

PMID:
30200703
2.

[Effects of total flavonoids in Astragali Complanati Semen on liver lipid level and ERα expression on liver in hyperlipidemia rats with kidney-Yang deficiency pattern].

Tang XR, Wang JX, Fu L, Yao JK, Li SM, Gao XM, Zhang JJ.

Zhongguo Zhong Yao Za Zhi. 2018 Jun;43(11):2365-2371. doi: 10.19540/j.cnki.cjcmm.20180408.002. Chinese.

PMID:
29945392
3.

Comparison of transitional vs surgical menopause on monoamine and amino acid levels in the rat brain.

Long T, Yao JK, Li J, Kirshner ZZ, Nelson D, Dougherty GG, Gibbs RB.

Mol Cell Endocrinol. 2018 Nov 15;476:139-147. doi: 10.1016/j.mce.2018.05.003. Epub 2018 May 5.

PMID:
29738870
4.

Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications.

Cai H, Cao T, Zhou X, Yao JK.

Front Psychiatry. 2018 Mar 8;9:73. doi: 10.3389/fpsyt.2018.00073. eCollection 2018. Review.

5.

Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia.

Cai H, Zhou X, Dougherty GG, Reddy RD, Haas GL, Montrose DM, Keshavan M, Yao JK.

Psychoneuroendocrinology. 2018 Apr;90:43-51. doi: 10.1016/j.psyneuen.2018.02.004. Epub 2018 Feb 7.

6.

Association between increased serum interleukin-6 levels and sustained attention deficits in patients with major depressive disorder.

Ye G, Yin GZ, Tang Z, Fu JL, Chen J, Chen SS, Li J, Fu T, Yu X, Xu DW, Yao JK, Hui L.

Psychol Med. 2018 Nov;48(15):2508-2514. doi: 10.1017/S0033291718000090. Epub 2018 Feb 8.

PMID:
29415791
7.

[Safety evaluation of Sophora tonkinensis and risk control].

Chen D, Gao XM, Zhang L, Fu L, Yao JK, Wang LL, Sun XB, Wang JX.

Zhongguo Zhong Yao Za Zhi. 2017 Nov;42(21):4086-4092. doi: 10.19540/j.cnki.cjcmm.20170919.010. Chinese.

PMID:
29271144
8.

Therapeutic efficacy of atypical antipsychotic drugs by targeting multiple stress-related metabolic pathways.

Cai HL, Jiang P, Tan QY, Dang RL, Tang MM, Xue Y, Deng Y, Zhang BK, Fang PF, Xu P, Xiang DX, Li HD, Yao JK.

Transl Psychiatry. 2017 May 16;7(5):e1130. doi: 10.1038/tp.2017.94.

9.

Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases.

Sun GY, Simonyi A, Fritsche KL, Chuang DY, Hannink M, Gu Z, Greenlief CM, Yao JK, Lee JC, Beversdorf DQ.

Prostaglandins Leukot Essent Fatty Acids. 2018 Sep;136:3-13. doi: 10.1016/j.plefa.2017.03.006. Epub 2017 Mar 10. Review.

PMID:
28314621
10.

A rapid UPLC-MS/MS assay for eicosanoids in human plasma: Application to evaluate niacin responsivity.

Miller TM, Poloyac SM, Anderson KB, Waddell BL, Messamore E, Yao JK.

Prostaglandins Leukot Essent Fatty Acids. 2018 Sep;136:153-159. doi: 10.1016/j.plefa.2017.01.003. Epub 2017 Jan 18.

PMID:
28111064
11.

Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study.

Lizano PL, Yao JK, Tandon N, Mothi SS, Montrose DM, Keshavan MS.

Schizophr Res. 2017 May;183:75-81. doi: 10.1016/j.schres.2016.11.015. Epub 2016 Nov 15.

12.

Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.

Lizano PL, Keshavan MS, Tandon N, Mathew IT, Mothi SS, Montrose DM, Yao JK.

Schizophr Res. 2016 Jan;170(1):115-22. doi: 10.1016/j.schres.2015.12.001. Epub 2015 Dec 11.

13.

A potential mechanism underlying atypical antipsychotics-induced lipid disturbances.

Cai HL, Tan QY, Jiang P, Dang RL, Xue Y, Tang MM, Xu P, Deng Y, Li HD, Yao JK.

Transl Psychiatry. 2015 Oct 20;5:e661. doi: 10.1038/tp.2015.161.

14.

Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia.

Yao JK, Dougherty GG Jr, Gautier CH, Haas GL, Condray R, Kasckow JW, Kisslinger BL, Gurklis JA, Messamore E.

Schizophr Bull. 2016 Mar;42(2):369-76. doi: 10.1093/schbul/sbv130. Epub 2015 Sep 14.

15.

Long-chain omega-3 fatty acids and optimization of cognitive performance.

Muldoon MF, Ryan CM, Yao JK, Conklin SM, Manuck SB.

Mil Med. 2014 Nov;179(11 Suppl):95-105. doi: 10.7205/MILMED-D-14-00168. Review.

16.

Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics.

McEvoy J, Baillie RA, Zhu H, Buckley P, Keshavan MS, Nasrallah HA, Dougherty GG, Yao JK, Kaddurah-Daouk R.

PLoS One. 2013 Jul 24;8(7):e68717. doi: 10.1371/journal.pone.0068717. Print 2013.

17.

Concurrent physical activity modifies the association between n3 long-chain fatty acids and cardiometabolic risk in midlife adults.

Muldoon MF, Erickson KI, Goodpaster BH, Jakicic JM, Conklin SM, Sekikawa A, Yao JK, Manuck SB.

J Nutr. 2013 Sep;143(9):1414-20. doi: 10.3945/jn.113.174078. Epub 2013 Jul 24.

18.

Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.

Yao JK, Dougherty GG, Reddy RD, Matson WR, Kaddurah-Daouk R, Keshavan MS.

Front Cell Neurosci. 2013 Jun 11;7:90. doi: 10.3389/fncel.2013.00090. eCollection 2013.

19.

Oxidative stress and therapeutic implications in psychiatric disorders.

Zhang XY, Yao JK.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:197-9. doi: 10.1016/j.pnpbp.2013.03.003. Epub 2013 Mar 21.

PMID:
23523744
20.

Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile.

Kaddurah-Daouk R, Yuan P, Boyle SH, Matson W, Wang Z, Zeng ZB, Zhu H, Dougherty GG, Yao JK, Chen G, Guitart X, Carlson PJ, Neumeister A, Zarate C, Krishnan RR, Manji HK, Drevets W.

Sci Rep. 2012;2:667. Epub 2012 Sep 19.

Supplemental Content

Loading ...
Support Center